← All stocks

Arbutus Biopharma Corp

ABUS No buying or selling
CIK 0001447028 #2587 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions

There is no salary here to measure against. Arbutus Biopharma Corp's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
McElhaugh Michael J.
Interim President & CEO
1,658,003
$5.44M
+10.2%
HASTINGS DAVID C
Chief Financial Officer
249,824
$820.17K
+37.3%
Sims Karen
Chief Medical Officer
155,494
$510.49K
+23.9%
Naftzger J. Christopher
General Counsel and CCO
140,544
$461.41K
+44.0%
Nguyen Tuan
Chief Financial Officer
73,500
$241.30K
Androski Lindsay
President and CEO
28,000
$91.92K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 6 Oct 2016